Shopping Cart
- Remove All
- Your shopping cart is currently empty
PHI-101 is an orally available and selective checkpoint kinase 2 (Chk2) inhibitor for the study of refractory acute myelogenous leukemia (AML) and ovarian cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $183 | In Stock | |
5 mg | $459 | In Stock | |
10 mg | $739 | In Stock | |
25 mg | $1,480 | In Stock | |
50 mg | $2,380 | In Stock | |
100 mg | $3,790 | In Stock | |
1 mL x 10 mM (in DMSO) | $493 | In Stock |
Description | PHI-101 is an orally available and selective checkpoint kinase 2 (Chk2) inhibitor for the study of refractory acute myelogenous leukemia (AML) and ovarian cancer. |
Alias | PHI101, PHI 101 |
Molecular Weight | 386.44 |
Formula | C19H19FN4O2S |
Cas No. | 2127107-15-5 |
Smiles | N(C(N)=O)C1=C(C(N[C@H]2CCCNC2)=O)SC(C#CC3=CC(F)=CC=C3)=C1 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (207.02 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.